Anthropic opens AI life sciences research to outside experts

Anthropic has announced an open call for guest investigators to participate in its life sciences AI research. The company is seeking outside experts to contribute to projects that apply artificial intelligence in biology, medicine, and related fields.

Why it matters

This move signals that Anthropic is looking for ideas and skills it does not already have in-house. Rather than building everything internally, the company is inviting researchers with practical experience in the life sciences to test and shape its AI models. For companies working in health, biotech, or pharmaceuticals, this could mean faster development of tools that use Anthropic’s AI for real-world problems.

Bringing in guest investigators also suggests Anthropic wants to compete with other AI firms that are already active in the life sciences. Alphabet’s DeepMind and startups like Recursive have made headlines for applying AI to scientific research. With outside experts, Anthropic could close the gap or find new commercial opportunities.

How the guest investigator program works

The open call, announced on Anthropic’s website, invites applicants from academia, industry, and the clinical sector. According to Anthropic, selected guest investigators will gain access to the company’s AI models and tools for use in life sciences research. Projects could cover areas such as genomics, drug discovery, diagnostics, or medical data analysis.

Anthropic has not specified any particular research topics or set a public deadline for applications. The company says that the program is intended to foster collaboration and accelerate progress at the intersection of AI and biology. Participants may work remotely or in partnership with Anthropic’s own teams, depending on the project.

By opening its research to outsiders, Anthropic is following a model used in other AI fields, where collaboration with domain experts often leads to more useful products. The company has not detailed how intellectual property or commercial rights will be handled, which could be a factor for business applicants.

What this means if you run a business

If you are in healthcare, biotech, or any sector that deals with large biological datasets, this announcement is worth attention. Anthropic’s guest investigator program could give your company early access to AI tools that might not be available on the open market. For some, joining as an investigator may also be a way to influence how Anthropic’s models get trained or validated in your specific use case.

The program may also be a signal for buyers and managers that Anthropic is serious about building domain-specific models, not just general-purpose AI. If your business has struggled to find AI tools that understand medical or biological data, partnerships like this could narrow the gap. Success will depend on how Anthropic manages collaboration and whether it can balance open research with protecting its own technology.

Other companies, such as Recursive, have used similar approaches to bring new AI applications to market faster. Companies that act early may get a technical or commercial edge as the field moves quickly.